Myeloma patients with even severe renal impairment should still have the opportunity to receive autologous stem cell transplants, according to data from the Australian and New Zealand Myeloma and Related Diseases Registry. A study of 843 patients, presented at the HAA 2017 Annual Scientific Meeting in Sydney, found no difference in clinical response rates to ...
Renal impairment not an excuse to deny ASCT in myeloma
By Mardi Chapman
1 Nov 2017